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Summary 
The molecular control of the distribution and motion of acetylcholine 
receptors in the plasma membrane of developing rat myotubes in primary cell 
culture was investigated by fluorescence techniques. Acetylcholine receptors 
were marked with tetramethylrhodamine-labeled a-bungarotoxin and lateral 
molecular motion in the membrane was measured by the fluorescence photo- 
bleaching recovery technique. Three types of experiments are discussed: 
(I) The effect of enzymatic cleavages, drugs, cross-linkers, and physiological 
alterations on the lateral motion of acetylcholine receptors and on the 
characteristic distribution of acetylcholine receptors into patch and diffuse 
areas. (II)Observation of the distribution and/or motion of fluorescence- 
labeled concanavalin A receptors, lipid probes, cell surface protein, and stained 
cholinesterase in acetylcholine receptor patch and diffuse areas. (III) The effect 
of a protein synthesis inhibitor and electrical stimulation on membrane 
incorporation of new acetylcholine receptors. 
Some of the main conclusions are: (a) acetylcholine receptor lateral motion 
is inhibited by concanavalin A plant lectin and by anti-a-bungarotoxin anti- 
body, but marginally enhanced by treatment with a local anesthetic; 
(b) patches are stabilized by an immobile cellular structure consisting of mole- 
cules other than the acetylcholine receptors themselves; (c)this structure is 
highly selective for acetylcholine receptors and not for other cell membrane 
components; (d) acetylcholine receptor patch integrity and diffuse area motion 
are independent of direct metabolic energy requirements and are sensitive to 
Abbreviations: TMR, te tramethylrhodamine;  IgG, imrnunoglobulin G; diI-C18-(3), dioctadecyl indo-  
carbocyanine;  LETS protein,  large, external, transformation-sensit ive protein; EGTA° ethyleneglycol -  
bis-(13-aminoethylether)-N,N'-tetraacetic acid. 
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electrical excitation of myotube; (e) lipid molecules can move laterally in both 
acetylcholine receptor patches and diffuse areas; and (f) acetylcholine receptor 
lateral motion in diffuse areas and immobility in patch areas are not altered by 
specific agents which are known to affect extrinsic cell surface proteins, or 
cytoplasmic microfilaments and microtubules. 
Introduction 
Studies of the appearance, distribution, and lateral motion of acetylcholine 
receptors on fused embryonic muscle cells are important to understanding the 
molecular sequence of events during neuromuscular synapse formation. Such 
studies are also potentially significant for understanding membrane structure 
and biophysics, for several reasons. First, the acetylcholine receptor is a well- 
de fned  membrane protein whose chemistry in vitro and physiological function 
in vivo have been extensively studied [1]. Second, the distribution and lateral 
mobility of acetylcholine receptors on the surface of developing muscle cells in 
primary culture [2--7] is heterogeneous, coexisting in both uniform diffuse 
regions at low surface density with significant lateral mobility, and in densely 
packed, speckly patches of immobilized acetylcholine receptors. Third, acetyl- 
choline receptors can be marked specifically and irreversibly by radioactivity or 
fluorescence-tagged a-bungarotoxin. 
In this paper, we describe experiments designed to yield information on the 
cellular mechanisms that control acetylcholine receptor distribution and 
motion on myotubes. Our results reveal several structural and dynamic relation- 
ships between acetylcholine receptors and certain other cellular components, 
and also exclude several otherwise reasonable models of the interaction 
between acetylcholine receptors and the cell surface. Three types of experi- 
ments are described: (a) the effect upon acetylcholine receptor motion and 
distribution of chemical agents which alter the molecular structure or 
physiology of the cell surface; (b)study of the motion and distribution of 
other specific cell surface constituents relative to the characteristic acetyl- 
choline receptor distribution; and (c) a limited study of treatments affecting 
cell surface acetylcholine receptor turnover rates. 
We performed all of the experiments upon primary cultures of embryonic rat 
muscle. Cell surface components were visualized by fluorescence microscopy 
by marking them with fluorescent groups; in particular, acetylcholine receptors 
were marked by tetramethylrhodamine a-bungarotoxin (TMR-a-bungarotoxin) 
[ 8]. Lateral motion of fluorescent molecules on the cell surface was measured 
by the fluorescence photobleaching recovery technique [9,10]. Fluorescence 
photobleaching recovery previously has been applied to study the lateral 
motion of a wide variety of model membrane [11,12] and cell surface 
[13--19] constituents including acetylcholine receptors on rat and chick 
myotubes [4,10]. 
Experimental procedures 
Culturing of rat myoblasts. The culturing procedure was performed as 
described previously [4]. Myoblasts usually began fusing with each other to 
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form myotubes  on or about  the third day after plating. The experiments on 
myotubes  described herein were performed on 4--10-day-Old cultures. 
Fluorescence-labeled a-bungarotoxin. We purified a-bungarotoxin from 
snake venom (Sigma) by the method of  Lee et al. [20]. We labeled the a- 
bungarotoxin with te tramethylrhodamine (TMR )as  described previously [8]. 
Fluorescein a-bungarotoxin was prepared by exactly the same procedure as 
TMR-a-bungarotoxin.  By this procedure, the final TMR-a-bungarotoxin 
preparation is monolabeled,  whereas the fluorescein-a-bungarotoxin is a mixture 
of  mono  and higher degrees of  labeling. 
TMR-a-bungarotoxin is monovalent  and is unlikely to cross-link or 
redistribute acetylcholine receptors. In addition, pre-fixing the myotubes  with 
formaldehyde does not  alter the TMR-a-bungarotoxin marking pattern, nor is 
the pattern qualitatively a function of  TMR-a-bungarotoxin incubation time 
on the myotubes .  
Other chemical agents. Concanavalin A was obtained from Miles-Yeda. 
Succinyl-concanavalin A, tetramethylrhodamine (TMR) concanavalin A and 
TMR-succinyl-concanavalin A were gifts of  Dr. Kenneth Jacobson. Concanavalin 
A-bound blood platelets were a gift of  Dr. Gerald Edelman. 
Cytocholasin B was obtained from Imperial Chemical Co.; collagenase and 
trypsin from Worthington Biochemical; colchicine, vinblastine, dithiothreitol,  
neuraminidase, hyaluronidase, puromycin • HC1, a-mannosidase and dibucaine 
from Sigma; and A23187 for Eli Lilly. 
Rabbi t  ant ibody to a-bungarotoxin was a gift of  Dr. Mathew Daniels; TMR- 
conjugated IgG fraction goat ant ibody to rabbit  IgG was obtained from Cappel 
Laboratories; dioctadecylindocarbocyanine (diI-Cls-(3)) was a gift of  Dr. Alan 
Waggoner. Ant ibody to 'cell surface protein '  (sometimes called 'large external 
transformation-sensitive' protein or LETS) was a gift of  Dr. Ira Pastan. Anti- 
LETS protein was labeled with TMR by the method of  Goldman [21].  
Fluorescence measurements. Fluorescence of  myotubes  adhering to the 
tissue culture dish was observed by a photomultipl ier  mounted  on a 
fluorescence microscope using vertical illumination through the objective. The 
568.2 nm or the 530.9 nm line of  a krypton laser was the excitation light 
source. We used a 40X, numerical aperture 0.75 microscope objective directly 
immersed in the Hank's balanced salt solution bathing the cells. The exact 
optical and electronic system is described elsewhere [ 10]. 
In applying the fluorescence photobleaching recovery technique to measure 
lateral molecular motion,  the fluorescence of  labeled molecules or probes in 
an approx. 3 pm 2 area on a cell surface is bleached by a 0.4 s pulse of  intense 
(about  1 mW/pm 2) focused laser light. The subsequent  lateral mot ion of  un- 
bleached fluorophore into the bleached area is measured by the recovery of  
fluorescence excited by the same, although much at tenuated (~ 104 times) laser 
beam, flashed at 0.4 s pulse duration every 4 s. The lateral mot ion was 
quanti tated in terms of  a two-dimensional diffusion constant,  calculated 
according to the method of  Axelrod et al. [9] by measuring the time required 
for the fluorescence to recover halfway from its immediate postbleach level to 
its long-time asymptot ic  level. The completeness of  the fluorescence recovery at 
long times was used as a measure of  the fraction f of the total f luorophore 
which is mobile [9]. 
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The bleaching laser pulse does not overheat the cell surface [22]. In addi- 
tion, prolonged illumination by laser light of higher power than that employed 
here has been observed to not affect the viability of other cell types 
(Schlessinger, J., personal communication). 
Results 
We performed three classes of experiments designed to probe the molecular 
interaction between acetylcholine receptors and the cell surface: (A)fluores- 
cence photobleaching recovery measurements and/or photographs of TMR-a- 
bungarotoxin-labeled myotubes before (as a control) and after treatment with 
various chemical agents; (B) fluorescence photobleaching recovery measure- 
ments on other fluorescence marked cell surface constituents in acetylcholine 
receptors patch vs. diffuse areas simultaneously visualized with fluorescein a- 
bungarotoxin by a fluorescence doubling labeling technique, and (C) fluores- 
cence observation of the slow (on the order of hours) turnover of acetyl- 
choline receptors in the presence and absence of electrical stimulation and 
protein synthesis inhibitor puromycin. 
TMR-a-bungarotoxin-acetylcholine receptor mot ion and distribution 
It has been shown in previous fluorescence photobleaching recovery work on 
rat myotubes [4] that acetylcholine receptors in high-density patches are 
immobile and the acetylcholine receptors in the remaining lower-density 
diffuse areas are mobile. We examined the effects of various chemical agents on 
the diffusion constant D of TMR~-bungarotoxin-acetylcholine receptor in 
diffuse areas and the presence and shape of TMR-~-bungarotoxin-acetylcholine 
receptor patches as recorded in sequential photographs over periods of 2--7 h. 
Table I lists the chemical agent, the treatment protocol, the fluorescence 
photobleaching recovery-measured diffusion constants D w and D c of the 
treated cultures and controls, respectively, and the corresponding fractions fT 
and fc of the total TMR-a-bungarotoxin-acetylcholine receptor vchich was 
mobile. Unless otherwise noted, the treatments were preceded by a standard 
protocol for TMR~-bungarotoxin labeling: 10-~M TMR-a-bungarotoxin in 
Hank's balanced salt solution for 1 h at 22°C followed by a 0.5--1 h wash (with 
several solution changes) in Hank's balanced salt solution containing 2 mg/ml 
bovine serum albumin. While we have not directly examined the effectiveness 
of the treatments employed on the expected sites of action, the conditions for 
each treatment were chosen as being effective in other cell systems. 
Three treatments affected TMR-a-bungarotoxin mobility in diffuse areas: 
tetravalent concanavalin A, anti~-bungarotoxin antibody (both decreasing 
the mobile acetylcholine receptor fraction), and dibucaine (marginally 
increasing the diffusion constant). Acetylcholine receptor visualization by 
TMR~-bungarotoxin was not inhibited or altered by prior (rather than post) 
treatment with concanavalin A. TMR-~-bungarotoxin motion appeared 
insensitive to all the other treatments, at least to within the uncertainty 
(generally + 50%) of the results. 
A significant fraction of the acetylcholine receptors in diffuse areas remained 
immobile despite the treatments administered to the cells. Using a high power 
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objective (numerical aperture 1.25), small clumps of acetylcholine receptors of 
diameter less than 1 tLm are occasionally visible; these acetylcholine receptor 
clumps in otherwise diffusely labeled areas may represent the immobile frac- 
tion. 
None of the treatments led to any dramatic redistribution of acetylcholine 
receptors noticeable upon observation several hours after the beginning of 
treatment. Although there was some internalization of fluorescence most likely 
due to acetylcholine receptor-TMR-a-bungarotoxin turnover [4], patches 
remained in approximately the same regions with the same highly speckled and 
granular internal structure after chemical treatment. If chemical treatment had 
altered the molecular mechanism confining acetylcholine receptors in patches, 
one would at least expect the fine structure of the patches to become blurred; 
this was not observed. In some instances, the treatment caused some myotubes 
to round up, a preliminary state before losing contact with the dish. In these 
cases, patches were occasionally still found on the rounded-up cell. 
Motion and distribution of  other membrane components 
In order to probe acetylcholine receptor interactions with other membrane 
proteins and lipids, we optically examined the distribution and motion of 
certain other myotube surface components. In particular, we discuss the 
following experiments in this section: (a) comparison of the motion of TMR- 
succinyl-concanavaiin A receptors in acetylcholine receptor diffuse regions vs. 
acetylcholine receptor patch regions as visualized by fluorescein-a-bungarotoxin; 
(b) a similar double-labeling experiment using fluorescent lipid probe diI-Cls- 
(3); (c) the  sensitivity of succinyl-concanavalin A motion to cytocholasin B 
treatment; and (d) comparison of the characteristic acetylcholine receptor 
distribution with the distributions of cholinesterases using the stain procedure 
of Karnovsky and Roots [23], and of cell surface protein (LETS protein) 
using direct antibody fluorescence staining. 
Unlike acetylcholine receptors, concanavalin A receptors were not grouped 
into large dense patches anywhere on the myotube surface, including in acetyl- 
choline receptor patch regions. In fact, local quantitative measurement of 
TMR-succinyl-concanavalinA fluorescence suggested that concanavalin A 
receptor density in acetylcholine receptor patches is only about 60 _+ 20% of 
that in acetylcholine receptor diffuse areas. The surface density of succinyl- 
concanavalin A in diffuse acetylcholine receptor areas was comparable to the 
local acetylcholine receptor density: 1000 molecules/gm 2. No minute high- 
density speckles or strands of concanavalin A receptors like those of acetyl- 
choline receptor were visible in patches. 
One might argue that a very high density of concanavalin A receptors might 
cause fluorescence self-quenching, thereby leading to a misinterpretation of 
low fluorescence. This situation seems unlikely here since the fluorescence of 
even very high density fluorescent concanavalin A receptors (10s--107/cell) in 
ligand induced caps on lymphocytes and other cells show no evidence of such 
drastic self-quenching. 
The results of fluorescence photobleaching recovery experiments the lateral 
motion of TMR-succinyl-concanavalin A are shown in Table II. The fractional 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































T A B L E  II 
F L U O R E S C E N C E  P H O T O B L E A C H I N G  R E C O V E R Y  R E S U L T S  F O R  L A T E R A L  M O B I L I T Y  O F  T M R -  
S U C C I N Y L - C O N C A N A V A L I N  A A N D  d i I -C18- (3 )  IN A C E T Y L C H O L I N E  R E C E P T O R  P A T C H  vs. DIF -  
F U S E  A R E A S  
These  were  double- label ing  e x p e r i m e n t s :  the  b e l o w  p r o t o c o l s  w e r e  p r e c e d e d  by  t r e a t m e n t  o f  cel ls  w i t h  
1 0  -7  M f l uoresce i n - hung ar o tox in  at 22*C for  1 h f o l l o w e d  by  0.5  h wa sh .  The d i I - C l s - ( 3 )  wa s  i n t r o d u c e d  
by  adding 1 0  ~1 o f  0 .3  m g / m l  di l -C 18"(3)  in e t h a n o l  to  1 m l  o f  Hank's  ba lanced  salt so lu t ion  bathing  the 
cells. The cel ls  for b o t h  the  TMR-succ iny l - concanava l in  A and d i I -C18- (3 )  e x p e r i m e n t s  w e r e  g r o w n  in 
m e d i u m  conta in ing  1 0  -5  M c y t o s i n e  arabinoside  during days  2 - - 4  a f ter  plating to  prevent  divis ion and 
pro l i ferat ion  o f  overgrowing  m o n o n u e l e a t e d  cells. 
Probe TMR-succ iny l - concanava l in  A diI-C 18- (3)  
C o n c e n t r a t i o n  1 0  ~ g / m l  see legend 
Durat ion  15  r a in  3 rain 
T e m p e r a t u r e  (*C) 2 2  37 
D p a t c h  (10  - 1 0  c m 2 / s )  0 .6  ± 0 .6  (6)  12  ± 3 (4)  
D di f fuse  ( 1 0  - 1 0  c m 2 / s )  0 .7  ± 0 .3  (10)  1 5  ± 3 (7)  
f p a t c h  0 .2  ± 0 .1  (6)  0 .7  -+ 0 .1  
f d i f fuse  0 .5  ± 0 .1  (10)  O.S ± 0 .1  
somewhat reduced relative to the concanavalin A fractional mobility in acetyl- 
choline receptor diffuse areas. However, a significant portion of  concanavalin A 
receptors in acetylcholine receptor patches remained mobile, with a diffusion 
constant similar to concanavaiin A receptors elsewhere on the myotube surface. 
Table II also shows fluorescence photobleaching recovery results on lateral 
mobility of lipids. We used dioctadecylindocarbocyanine (diI-Cls-(3) as a 
fluorescent probe of membrane lipid regions [10,11,13,24,25]. The mobility of 
diI-Cla-(3) was unimpaired by the high concentration of acetylcholine receptor 
molecules in a patch, relative to the diI-Cla-(3) mobility elsewhere on the 
surface. The surface densities of diI-Cl8-(3) in acetylcholine receptor patch and 
diffuse areas were similar. The diI-Cla-(3) labeling was fairly uniform on the cell 
surface except for occasional labeled strands above the surface and occasional 
slight internalization (see Discussion). 
Although acetylcholine receptor was unaffected by cytocholasin B treatment, 
concanavaiin A receptor fractional mobility was substantially decreased by the 
identical treatment, as shown in Table III. 
Since acetylcholinesterase and acetylcholine receptor are both localized at 
adult motor endplates, we stained TMR-bungarotoxin-labeled myotubes by the 
Karnovsky-Roots method to determine if cholinesterases were localized in 
T A B L E  III 
T H E  E F F E C T  O F  C Y T O C H O L A S I N  B T R E A T M E N T  O N  T M R - S U C C I N Y L - C O N C A N A V A L I N  A MO- 
B I L I T Y  
See  Table  I, e x p e r i m e n t  G for  p r o t o c o l .  The  cel ls  w e r e  g ro wn  in m e d i u m  conta in ing  10  -5  M c y t o s i n e  
axabinoside on  days  2 - - 4  a f ter  plat ing.  "CB" subscript  refers  to  c y t o c h o l a s i n  B; " C o n t "  refers  t o  c o n t r o l  
( w i t h o u t  c y t o c h o l a s i n  B). 
Parameter  Value  
D C B  ( 1 0  - 1 0  c m 2 / s )  0 .8  + 0 .2  (4)  
D C o n t  ( 1 0  - 1 0  c m 2 / s )  0 .6  ± 0 . 2  (5) 
fCB 0 . 2 7  ± 0 . 0 4  (4)  
f C o n t  0 . 5 3  ± 0 . 1 3  (5)  
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acetylcholine receptor patches. Only very light cholinesterase staining was 
detected, with no special higher density at acetylcholine receptor patches. 
We observed the distribution of cell surface protein, otherwise called "large 
external transformation-sensitive" protein [ 15,26], giving special attention to 
labeling pattern of TMR-anti-LETS protein antibody on a myotube in the 
vicinity of an acetylcholine receptor patch (which could be visualized with 
fluorescein~-bungarotoxin). LETS protein labeled in a network of thin strands 
on the edge of cells in a manner entirely dissimilar to the typical patch-and- 
diffuse acetylcholine receptor distribution. 
It is conceivable that the lack of high-density decoration of acetylcholine 
receptor patch regions by TMR-succinyl-concanavalin A, cholinesterase stain, 
and TMR-anti-LETS protein arises from an accessibility problem. For example, 
since most (but not  all) acetylcholine receptor patches are on the bot tom 
surface of the myotubes,  perhaps large labeled proteins cannot "f i t"  in some 
areas between the dish and the cell. We tested this possibility by using indirect 
antibody fluorescent staining with fluorescein-~-bungarotoxin followed by 
rabbit anti-a-bungarotoxin antibody followed TMR-anti-rabbit IgG. Some 
acetylcholine receptor patches could be visualized by this technique, although 
the patch labeling was less intense, more speckled and more annular than the 
typical TMR-a-bungarotoxin patch labeling. We conclude that at least part of 
the patch is accessible to binding by large proteins such as antibodies (and also 
that fluorescein labeling does not  destroy the antigenicity of anti-a-bungaro- 
toxin. 
Turnover 
Acetylcholine receptors undergo a continual turnover, with half-times for 
membrane incorporation of new acetylcholine receptors and for internaliza- 
tion of old acetylcholine receptors on the order of 12--24 h [4,27]. When 
visualized by TMR-a-bungarotoxin, acetylcholine receptor internalization is 
manifested by the slow internalization of surface TMR fluorescence. New 
acetylcholine receptor incorporation is seen by appearance of new TMR-~- 
bungarotoxin binding sites after blockage of old acetylcholine receptor with 
unlabeled ~-bungarotoxin [4]. 
In the present series of experiments, we have verified that these "new" 
acetylcholine receptors are not  simply pre-existing membrane acetylcholine 
receptors from which ~-bungarotoxin has become unbound. A 3.5 h treatment 
with the protein synthesis inhibitor puromycin • (HC1) (at 20 ~g]ml in medium 
at 37°C) before and during a 1 h ~-bungarotoxin acetylcholine receptor 
blockage treatment, followed by an additional 6 h in puromycin (at the same 
concentration) prevented the appearance of TMR-~-bungarotoxin visualized 
new acetylcholine receptors. A control dish not  treated with puromycin but  
otherwise similarly treated did show labeling of newly incorporated acetyl- 
choline receptors in the same time period. In like manner, we have demon- 
strated the irreversibility of TMR~-bungarotoxin by assaying after several 
hours for the appearance of new acetylcholine receptor with fluorescein-~- 
bungarotoxin. 
The lifetime of a myotube acetylcholine receptor patch is on the order of 
days [4], considerably longer than the surface lifetime of the individual acetyl- 
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choline receptor molecules of which it is comprised. This observation raises the 
question of where newly incorporated acetylcholine receptors first appear in an 
already existing patch. We visualized new acetylcholine receptor incorporation 
by labeling with TMR-~-bungarotoxin several hours after saturation blockage 
and visualization of pre-existing acetylcholine receptors by fluorescein-~- 
bungarotoxin. (The excitation and emission spectra of fluorescein-~-bungaro- 
toxin and TMR-~-bungarotoxin are non-overlapping, so their labeling patterns 
are easily distinguishable). We found that newly incorporated acetylcholine 
receptors appear uniformly throughout the area of a patch, rather than 
selectively in, for example, the center of the patch or in an annular ring around 
its periphery. 
The rate of new acetylcholine receptor incorporation may be somewhat 
variable from myotube to myotube, and even from patch to patch on the same 
myotube; the fluorescence intensity of TMR-~-bungarotoxin-acetylcholine 
receptor patches labeled several hours after ~-bungarotoxin blockage ranged 
from very dim to quite bright. 
General electrical stimulation of the myotubes in the dish had a profound 
effect on the presence of acetylcholine receptors. 38 h of 20 V pulses (groups 
of 20 pulses of 3 ms duration every 10 s) applied across agar-buffer electrodes 
spaced 2 cm apart immersed in the medium caused at least a 5-fold reduction 
in the number of patches/unit length of myotube, relative to unstimulated 
dishes. Stimulated myotubes whose action potentials were blocked with 2" 
10-SM tetrodotoxin did not show a reduction in number of acetylcholine 
receptor patches, so it appears that the action potential or the ensuing contrac- 
tion is causally related to the acetylcholine receptor patch disappearance. In 
addition to the effect on patches, stimulation for greater than 20 h reduced the 
diffuse area acetylcholine receptor density by a factor of about 1/3 relative to 
the unstimulated or tetrodotoxin-blocked controls. Qualitatively similar effects 
of stimulation have been observed by Cohen and Fischbach [28] on chick 
primary myotubes. We do not yet know whether the stimulation effect results 
from enhanced removal or decreased new incorporation of patch acetylcholine 
receptors into the membrane. 
Discussion 
The localization and perhaps mobility of specific membrane proteins play a 
critical role in the development of multicellular systems. We discuss here the 
following questions about the molecular dynamics of acetylcholine receptors in 
the myotube membrane: (A) What maintains the acetylcholine receptor patch 
structure? (B)What controls the lateral motion of acetylcholine receptors in 
diffuse areas? (C)What is the relevance of myotube acetylcholine receptor 
patch and diffuse area distribution to adult muscle acetylcholine receptor 
distribution? 
(A ) Maintenance of acetylcholine receptor patch structure 
Some inferences concerning the structure of acetylcholine receptor patches 
can be drawn from results presented previously [4]. Acetylcholine receptors 
are continually incorporated into and removed from a patch although the patch 
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as a structure is relatively stable. From where do newly incorporated patch 
acetylcholine receptors come? They do not come from neighboring diffuse 
areas: we have shown previously that patch and diffuse areas exchange acetyl- 
choline receptors very slowly, if at all [4]. Therefore, the cell must possess an 
immobile, stable structure which assembles new acetylcholine receptors in the 
vicinity of a pre-existing patch, guides newly synthesized intracellular acetyl- 
choline receptors to a pre-existing patch region, or perhaps lenghens acetyl- 
choline receptor lifetime in a patch. 
It seems unlikely that this immobile structure consists solely of the patch 
acetylcholine receptors already present in the membrane. If high densities of 
acetylcholine receptors could alone somehow attract new acetylcholine 
receptors or lengthen membrane lifetime of patch acetylcholine receptors, one 
would expect new patches to form frequently in previously diffuse areas where 
concentration fluctuations of mobile acetylcholine receptors create transient 
local high acetylcholine receptor densities. However, such ongoing formation 
of new patches in previously diffuse areas has never been observed on rat 
myotubes. Therefore, it seems probable that some immobile molecular or sub- 
cellular system other than acetylcholine receptors plays a role in maintaining 
the stability of a patch structure. The highly granular patch fine structure of 
relatively immobile speckles and continuous strands also suggests the existence 
of a fixed non-acetylcholine receptor structure, perhaps even a filamentous 
structure to which lines of acetylcholine receptors attach. 
Although the long-term existence and stability of a patch appear to involve 
non-acetylcholine receptor structures, the immobility of acetylcholine 
receptors within a patch could still directly involve only acetylcholine receptor 
molecules. In analogy with a recent proposal [29] and results [30--32] con- 
cerning possible structural differences between classes of acetylcholine 
receptors from the same cell, it is possible that myotube patch acetylcholine 
receptors have a different molecular structure than diffuse acetylcholine 
receptors. Perhaps this difference allows only patch acetylcholine receptor 
molecules to "stick" to each other in patch areas, thereby immobilizing them- 
selves. However, this hypothesis still requires some non-acetylcholine receptor 
patch structure to maintain particular membrane regions as patch-type acetyl- 
choline receptor repositories. 
The remarkable integrity of patches under attack by detergent (Table I, 
column P), protease (columns K, L), disulfide bond cleavage (column H), 
glycosidases (columns M, N, O) and divalent ion chelation (column Q), even to 
the point of removing cells from the dish, indicates that patches are not 
stabilized by cell surface extrinsic proteins or other externally accessible 
structures. This situation contrasts strongly with that of certain other cell 
surface proteins. Trypsin, for example, under the conditions used here nearly 
completely removes all the LETS proteins from the cells [26]. Yet no effect of 
trypsin on acetylcholine receptors was observed. 
Although patch stability is maintained by cytoplasmic or inassessible intra- 
membrane structures, the external cell surface does appear to be involved in the 
formation of a new patch, perhaps through some mechanism based on physical 
contact with outside objects. The evidence for this is the preferential 
occurrence of rat myotube patches on the surface of the myotube in closest 
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contact to the tissue culture plastic [4,7]. On L6 cloned rat myotubes (which 
normally do not show acetylcholine receptor patches), external treatment with 
nerve extract can induce patches [33]. Therefore, although patches are 
stabilized by a structure inaccessible to the exterior, treatments originating 
from the exterior can induce patch appearance. 
The stability of patches during attack by colchicine or cytocholasin B 
(columns F and G) indicates that the targets of these drug (presumably 
including cytoplasmic microtubules and microfilaments) are not alone involved 
in patch structure. 
The lack of similarity between the distribution pattern of acetylcholine 
receptors and that of concanavalin A, LETS protein, cholinesterases, and diI- 
C,8-(3) emphasizes how selective must be the cellular mechanisms that control 
acetylcholine receptor distribution. Specifically, such selectivity argues againt 
simple membrane folding (e.g. like that of adult postsynaptic membrane) or 
any other mechanism that non-specifically concentrates membrane molecules 
into a small lateral area. For chick myotube acetylcholine receptor clusters, the 
same conclusion was reached using thin section electron microscopy [34]. 
The diI-Cls-(3)/fluorescein~-bungarotoxin double-labeling results show that 
the acetylcholine receptors in patches do not impede the lateral motion of 
lipid-like molecules over micron-scale distances. Acetylcholine receptors may 
be closely packed in individual small speckles in a patch region, but the 
membrane-imbedded portion of these speckles must be small enough (41 pm 2) 
and spaced widely enough to allow the motion of diI-Cls-(3) molecules around 
them. 
A portion of the diI-C~8-(3) becomes noticeably internalized into the cyto- 
plasm in about 1 h on rat primary myotubes at 22°C. This internalization is 
manifested by (a) fluorescence originating from planes of focus throughout the 
bulk of the myotube thickness rather than just the surfaces; (b) spatially 
inhomogeneous labeling of organelles; and (c ) distinct fluorescent exclusion 
from the nucleii. Our experiments were performed well before optically notice- 
able internalization, but some possible diI-C~a-(3) labeling of amphipathic 
submembrane structures may have contributed to the fluorescent intensity and 
fluorescence photobleaching recovery mobility results. Perhaps the 1/3 
immobility fraction of diI-C,8-(3) noticed in both acetylcholine receptor patch 
and diffuse areas represented diI-C,s-(3) bound to immobile structures 
immediately above or below the plasma membrane bilayer. 
(B) Control of  acetylchoIine receptor motion in diffuse areas 
Our results show the dynamic behavior of acetylcholine receptors in diffuse 
areas to be somewhat different than that of certain other membrane proteins. 
For example, we have shown here that cytocholasin B decreases the mobility of 
concanavalin A receptors on rat primary myotubes in a manner similar to 
cytocholasin B's effect on concanavalin A receptors [13], general surface pro- 
teins [14] and IgE-Fc receptors [17] on other cell types. Cytocholasin B, how- 
ever, does not alter the motion of acetylcholine receptors in the diffuse areas. 
This experiment clearly shows that the concanavalin A receptors and acetyl- 
choline receptors are different classes of proteins and that they differ in their 
interaction with cytoskeletal elements. 
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These two classes of proteins nevertheless can interact with each other. 
Concanavalin A receptors which have been immobilized by cross-linking 
through tetravalent concanavalin A can inhibit acetylcholine receptor motion. 
The molecular interpretation of this result is somewhat complex. Acetylcholine 
receptors in vitro bind concanavalinA [35]; if they do so in vivo, then 
concanavalin A receptor cross-linking by tetravalent concanavalin A would 
directly involve acetylcholine receptors, and hence concanavalin A would 
inhibit acetylcholine receptor motion,  as observed. However, concanavalin A 
receptors and diffuse area acetylcholine receptors appear to be distinct, as 
explained above. Also, the lack of high concentration TMR-succinyl- 
concanavalin A labeling on acetylcholine receptor patches and on intrapatch 
speckles argues against concanavalin A binding to patch acetylcholine receptors. 
Indeed, the TMR-succinyl-concanavalinA concentration in acetylcholine 
receptor patches is lower than elsewhere on the myotube surface. Assuming, 
then, that membrane acetylcholine receptors do not  bind concanavalin A 
significantly, then the concanavalin A-induced inhibition of TMR-a-bungaro- 
toxin-acetylcholine receptor mobility must be due to a more indirect effect. 
Perhaps acetylcholine receptors are "caged in" by surrounding cross-linked 
immobilized concanavalinA receptors. Or perhaps, the concanavalinA 
receptors and acetylcholine receptors are connected directly or indirectly via 
cytoskeletal filaments; certain interprotein filamentous connections are 
inferred from studies on lymphocytes [36]. If such connections exist here, 
they probably do not  involve only microtubules, since vinblastine treatment 
(experiments D and E in Table I) will not  release the concanavalin A-induced 
acetylcholine receptor mobility inhibition. The concanavalin A-platelet experi- 
ments (see also ref. 16) show that concanavalin A inhibition of TMR-a- 
bungarotoxin-acetylcholine receptor mobility is a local effect, confined to 
within less than 3 ~m from locally bound concanavalin A. 
Acetylcholine receptor motion can also be inhibited by treatment with a- 
bungarotoxin followed by anti~-bungarotoxin antibody, probably through 
extensive cross-linking of acetylcholine receptors via antibody molecules. This 
cross-linking involves no optically observable acetylcholine receptor redistribu- 
tion, in contrast to anti-antibody cross-linking-induced receptor redistributions 
seen on other cell types [37]. The acetylcholine receptor immobilization by 
concanavalin A and by  anti-a-bungarotoxin observed here should become a 
useful future tool for inhibiting developmental or externally-induced acetyl- 
choline receptor redistributions. 
The possibility that acetylcholine receptor motion is modulated by lipid 
ordering or acetylcholine receptor-lipid interactions is supported by the effect 
of dibucaine (J) in marginally increasing the acetylcholine receptor diffusion 
constant. Dibucaine would be expected to disorder lipid [38] and perhaps alter 
protein-lipid interactions. On the other hand, alteration of phospholipid fatty 
acyl composition and saturation does not  affect acetylcholine receptor 
mobility on chick myotubes [ 10]. 
Acetylcholine receptor lateral motion appears to be a passive process, inas- 
much as it is not  affected by blockage of the oxidative phosphorylation and/or 
glycolytic pathways (Column I, Table I). As with acetylcholine receptor patch 
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stability, acetylcholine receptor lateral motion in diffuse areas is not  modulated 
by a variety of externally exposed surface constituents. 
(C) Patches vs. endplates: acetylcholine receptor turnover 
Despite the concentrated, immobilized nature ,)f both myotube patch acyl- 
choline receptors and the junctional acetylcholine receptors in adult motor  
endplates, the disappearance of patches upon prolonged electrical stimulation 
reported on chick myotubes [28] and on our rat myotubes,  points to a major 
structural or biochemical difference between myotube acetylcholine receptor 
patches and the junctional acetylcholine receptor localization at adult motor  
endplates. The disappearance of myotube patches upon prolonged electrical 
stimulation is in closer analogy with denervated extrajunctional acetylcholine 
receptors (which decrease in concentration upon stimulation of the denervated 
muscle) than with junctional acetylcholine receptors. Myotube diffuse area 
acetylcholine receptors are also decreased in density, but not  nearly as dramati- 
cally as the number of surface patches. This difference may indicate that 
different cellular mechanisms control patch and diffuse acetylcholine receptors 
presence on the membrane. 
Ravdin [39] has shown that exposing myotubes to 0.5 mM dibutyryl cyclic 
AMP + 5 gM RO-20-1724 (a phosphodiesterase inhibitor) in the medium for 
24--48 h prior to TMR-bungarotoxin labeling also leads to at least a 5-fold 
reduction of number of patches/unit length of myotube,  although the diffuse 
acetylcholine receptor surface density appears unaffected. Dibutyryl cyclic 
AMP causes a marked increase in spontaneous twitching which might account 
for the similarity of effects of dibutyryl cyclic AMP and direct stimulation on 
acetylcholine receptor patch frequency. The regular spontaneous twitching 
which occurs in older myotube cultures may be responsible for the previously 
observed gradual disappearance of the patches [4] on such myotubes.  
(D ) Conclusions 
On the basis of both the positive and negative results presented here, we 
postulate several conclusions concerning the mechanisms that control acetyl- 
choline receptor motion and distribution. We believe that acetylcholine 
receptor patches are specifically stabilized by an immobile, intra- or sub- 
membrane filamentous structure, composed of molecules other than the acetyl- 
choline receptors themselves. This structure is attached to either: (a) otherwise 
mobile acetylcholine receptors thereby forming a patch; or (b) only "special" 
acetylcholine receptors which are capable of immobilizing themselves by self- 
cross-linking. The attachment of acetylcholine receptors to such a structure is 
reversible during the normal course of acetylcholine receptor turnover. The 
points of attachment, or the filamentous structure itself, can be dismantled by 
the cell upon prolonged electrical stimulation. Acetylcholine receptor packing 
in patches is open enough to allow unretarded lateral motion of membrane 
lipids. Acetylcholine receptor motion in diffuse areas can be somewhat 
dependent on lipid interactions and can be inhibited by ligand-mediated cross- 
linking, either directly, or indirectly through lectin receptors. Finally, the 
cellular mechanisms determining myotube acetylcholine receptor motion and 
distribution appear to be different from those operational in adult muscle. 
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